168 related articles for article (PubMed ID: 19943589)
1. Morbidity and mortality after induction chemotherapy followed by surgery in IIIa-N2 non small cell lung cancer.
Borreman P; De Leyn P; Decaluwé H; Moons J; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Acta Chir Belg; 2009; 109(3):333-9. PubMed ID: 19943589
[TBL] [Abstract][Full Text] [Related]
2. Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer.
Tanaka F; Yokomise H; Soejima T; Uramoto H; Yamanaka T; Nakagawa K; Yamamoto N; Nishimura Y; Niwa H; Okada M; Nakagawa T; Yamashita M
Ann Thorac Surg; 2018 Oct; 106(4):1018-1024. PubMed ID: 29890150
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.
Peer M; Stav D; Cyjon A; Sandbank J; Vasserman M; Haitov Z; Sasson L; Schreiber L; Ezri T; Priel IE; Hayat H
Heart Lung Circ; 2015 Jan; 24(1):69-76. PubMed ID: 25086910
[TBL] [Abstract][Full Text] [Related]
4. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
5. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
6. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
[TBL] [Abstract][Full Text] [Related]
7. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
[TBL] [Abstract][Full Text] [Related]
8. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H
J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497
[TBL] [Abstract][Full Text] [Related]
9. Sleeve lobectomy after induction chemoradiotherapy.
Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
[TBL] [Abstract][Full Text] [Related]
11. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
[TBL] [Abstract][Full Text] [Related]
12. Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.
Gonzalez M; Litzistorf Y; Krueger T; Popeskou SG; Matzinger O; Ris HB; Gronchi F; Lovis A; Peters S
Ann Thorac Surg; 2013 Jul; 96(1):247-52. PubMed ID: 23684158
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
[TBL] [Abstract][Full Text] [Related]
14. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry.
Arndt AT; Brunelli A; Cicconi S; Falcoz PE; Salati M; Kozower B; Liptay MJ; Rocco G; Karush JM; Geissen N; Basu S; Seder CW
Lung; 2021 Jun; 199(3):311-318. PubMed ID: 33909135
[TBL] [Abstract][Full Text] [Related]
15. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy.
Voltolini L; Luzzi L; Ghiribelli C; Paladini P; Di Bisceglie M; Gotti G
Eur J Cardiothorac Surg; 2001 Dec; 20(6):1106-12. PubMed ID: 11717012
[TBL] [Abstract][Full Text] [Related]
16. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
Johnstone DW; Byhardt RW; Ettinger D; Scott CB
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):365-9. PubMed ID: 12243809
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for bronchopleural fistula after right pneumonectomy: does eliminating the stump diverticulum provide protection?
Birdas TJ; Morad MH; Okereke IC; Rieger KM; Kruter LE; Mathur PN; Kesler KA
Ann Surg Oncol; 2012 Apr; 19(4):1336-42. PubMed ID: 22045468
[TBL] [Abstract][Full Text] [Related]
18. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients.
Stamatis G; Djuric D; Eberhardt W; Pöttken C; Zaboura G; Fechner S; Fujimoto T
Eur J Cardiothorac Surg; 2002 Aug; 22(2):292-7. PubMed ID: 12142202
[TBL] [Abstract][Full Text] [Related]
19. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
20. Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.
Yang CJ; McSherry F; Mayne NR; Wang X; Berry MF; Tong B; Harpole DH; D'Amico TA; Christensen JD; Ready NE; Klapper JA
Ann Thorac Surg; 2018 Mar; 105(3):924-929. PubMed ID: 29258674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
